These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1416849)

  • 1. Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus.
    Yeaman MR; Norman DC; Bayer AS
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1665-70. PubMed ID: 1416849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro.
    Yeaman MR; Sullam PM; Dazin PF; Bayer AS
    Infect Immun; 1994 Aug; 62(8):3416-23. PubMed ID: 8039912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro.
    Yeaman MR; Norman DC; Bayer AS
    Infect Immun; 1992 Jun; 60(6):2368-74. PubMed ID: 1587603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.
    Mercier RC; Dietz RM; Mazzola JL; Bayer AS; Yeaman MR
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2551-7. PubMed ID: 15215108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillin-induced killing and postantibiotic effect in oral streptococci are enhanced by platelet microbicidal proteins.
    Lee SY; Choe SJ
    Int J Antimicrob Agents; 2004 May; 23(5):457-61. PubMed ID: 15120723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.
    Yeaman MR; Puentes SM; Norman DC; Bayer AS
    Infect Immun; 1992 Mar; 60(3):1202-9. PubMed ID: 1541535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
    Dhawan VK; Yeaman MR; Bayer AS
    J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.
    Dhawan VK; Bayer AS; Yeaman MR
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3206-9. PubMed ID: 11036055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.
    Yeaman MR; Bayer AS; Koo SP; Foss W; Sullam PM
    J Clin Invest; 1998 Jan; 101(1):178-87. PubMed ID: 9421480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates.
    Wu T; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 1994 Apr; 38(4):729-32. PubMed ID: 8031037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source.
    Fowler VG; McIntyre LM; Yeaman MR; Peterson GE; Barth Reller L; Corey GR; Wray D; Bayer AS
    J Infect Dis; 2000 Oct; 182(4):1251-4. PubMed ID: 10979928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
    Knapp CC; Washington JA
    Antimicrob Agents Chemother; 1986 Dec; 30(6):938-9. PubMed ID: 3028254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.
    Iluz N; Maor Y; Keller N; Malik Z
    Lasers Surg Med; 2018 Jul; 50(5):535-551. PubMed ID: 29333608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial/anti-biofilm activity of expired blood platelets and their released products.
    Różalski MI; Micota B; Sadowska B; Paszkiewicz M; Więckowska-Szakiel M; Różalska B
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():321-5. PubMed ID: 23619231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics.
    Chuard C; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1993 Apr; 37(4):625-32. PubMed ID: 8494358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.
    Sakoulas G; Eliopoulos GM; Fowler VG; Moellering RC; Novick RP; Lucindo N; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2687-92. PubMed ID: 15980337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus.
    Bakar NS; Zin NM; Basri DF
    Pak J Pharm Sci; 2012 Jul; 25(3):633-8. PubMed ID: 22713953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro.
    Yeaman MR; Ibrahim AS; Edwards JE; Bayer AS; Ghannoum MA
    Antimicrob Agents Chemother; 1993 Mar; 37(3):546-53. PubMed ID: 8460923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.